Trial Profile
A retrospective observational study comparing adherence and exacerbations in asthma patients receiving Fluticasone Furoate/Vilanterol and Twice Daily Budesonide/Formoterol in a US health care database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Vilanterol/fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 11 Jul 2017 New trial record
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society